Hinge-loop mutation can be used to control 3D domain swapping and amyloidogenesis of human cystatin C

Journal of Structural Biology

Volumn 173, Issue 2, 2011, Pages 406-413

  Orlikowska, Marta ^a   Jankowska, Elbieta ^a   Kołodziejczyk, Robert ^b   Jaskólski, Mariusz ^b,c   Szymańska, Aneta ^a  

^a UNIVERSITY OF GDA SK   (Poland)

^b ADAM MICKIEWICZ UNIVERSITY   (Poland)

^c INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

Author keywords

3D domain swapping; Amyloid; Crystal structure; Cysteine protease inhibitor; Protein aggregation

Indexed keywords

AMYLOID; CYSTATIN; CYSTATIN C; CYSTEINE PROTEINASE; DISULFIDE; MONOMER;

ALPHA HELIX; ARTICLE; DIMERIZATION; HUMAN; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

ANIMALS; CYSTATIN C; CYSTATINS; HUMANS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY;

ANIMALIA;

EID: 78751585161     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2010.11.009     Document Type: Article

References (41)

1. Abrahamson M., Grubb A. Increased body temperature accelerates aggregation of the Leu-68→Gln mutant cystatin C, The amyloid-forming protein in hereditary cystatin C amyloid angiopathy. Proc. Natl. Acad. Sci. USA 1994, 91:1416-1420.
2. Bode W., Engh R., Musil D., Thiele U., Huber R., Karshikov A., Brzin J., Kos J., Turk V. The 2.0Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J. 1988, 7:2593-2599.
3. Brünger A.T. The free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 1992, 355:472-474.
4. Collaborative Computational Project, Number 4 The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 1994, 50:760-763.
5. Deane C.M., Allen F.H., Taylor R., Blundell T.L. Carbonyl-carbonyl interactions stabilize the partially allowed Ramachandran conformations of asparagine and aspartic acid. Protein Eng. 1999, 12:1025-1028.
6. Debnath P., Chakrabarti P. On residues in the disallowed region of the Ramachandran map. Biopolymers 2002, 63:195-206.
7. Dehouck Y., Biot Ch., Gills D., Kwasigroch J.M., Rooman M. Sequence-structure signals of 3D domain swapping in proteins. J. Mol. Biol. 2003, 330:1215-1225.
8. DeLano, W.L., 2002. The PyMOL Molecular Graphics System. DeLano Scientific, San Carlos, CA, USA. http://www.pymol.org.
9. Ding F., Prutzman K.C., Campbell S.L., Dokholyan N.V. Topological determinants of protein swapping. Structure 2006, 14:5-14.
10. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 2004, 60:2126-2132.
11. Engh R.A., Dieckmann T., Bode W., Auerswald E.A., Turk V., Huber R., Oschkinat H. Conformational variability of chicken cystatin. Comparison of structures determined by X-ray diffraction and NMR spectroscopy. J. Mol. Biol. 1993, 234:1060-1069.
12. Gille C., Frommel C. STRAP: editor for STRuctural Alignments of Proteins. Bioinformatics 2001, 17:377-378.
13. Grubb Cystatin C - properties and use as diagnostic marker. Adv. Clin. Chem. 2000, 35:63-99.
14. Gudmundsson G., Hallgrimsson J., Jonasson T.A., Bjarnason O. Hereditary cerebral hemorrhage with amyloidosis. Brain 1972, 95:387-404.
15. Henskens M.C., Veerman E.C.I., Amerongen A.V.N. Cystatins in health and disease. Biol. Chem. 1996, 377:71-86.
16. Jankowska, E., Orlikowska, M., Radulska, A., Szymańska, A. 2009. Are V57 mutants of amyloidogenic protein - human cystatin C more or less resistant to denaturation conditions? In: Lankinen, H. (Ed.), Peptides 2008, Proc. 30th European Peptide Symposium. Finnish Peptide Society.
17. Janowski R., Kozak M., Jankowska E., Grzonka Z., Grubb A., Abrahamson M., Jaskólski M. Human cystatin C, an amyloidogenic protein dimerizes through three-dimensional domain swapping. Nat. Struct. Biol. 2001, 8:316-320.
18. Janowski R., Abrahamson M., Grubb A., Jaskólski M. Domain swapping in N-truncated human cystatin C. J. Mol. Biol. 2004, 341:151-160.
19. Janowski R., Kozak M., Abrahamson M., Grubb A., Jaskólski M. 3D domain-swapped human cystatin C with amyloidlike intermolecular beta-sheets. Proteins 2005, 61:570-578.
20. Jaskolski M. 3D Domain swapping, protein oligomerization, and amyloid formation. Acta Biochim. Pol. 2001, 48:807-827.
21. Kolodziejczyk R., Michalska K., Hernandez-Santoyo A., Wahlbom M., Grubb A., Jaskolski M. Crystal structure of human cystatinC stabilized against amyloid formation. FEBS J. 2010, 277:1726-1737.
22. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26:283-291.
23. Levy E., Sastre M., Kumar A., Gallo G., Piccardo P., Ghetti B., Tagliavini F. Co-deposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J. Neuropathol. Exp. Neurol. 2001, 60:94-104.
24. Maiti R., Van Domselaar G.H., Zhang H., Wishart D.S. SuperPose: a simple server for sophisticated structural superposition. Nucleic Acids Res. 2004, 32:590-594.
25. Martin J.R., Craven C.J., Jerala R., Kroonzitko L., Žerovnik E., Turk V., Waltho J.P. The three-dimensional solution structure of human stefin A. J. Mol. Biol. 1995, 246:331-343.
26. Murshudov G.N., Vagin A., Dodson E. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 1997, 53:240-255.
27. Neu H.C., Heppel L.A. The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts. J. Biol. Chem. 1965, 249:3685-3692.
28. Nilsson M., Wang X., Rodziewicz-Motowidlo S., Janowski R., Lindstrom V., Onnerfjord P., Westermark G., Jaskolski M., Grubb A. Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C: use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomeric form of cystatin C. J. Biol. Chem. 2004, 279:24236-24245.
29. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997, 276:307-326.
30. Painter J., Merritt E.A. TLSMD web server for the generation of multi-group TLS models. J. Appl. Crystallogr. 2005, 39:109-111.
31. Painter J., Merritt E.A. Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr. D 2006, 62:439-450.
32. Potterton E., Briggs P., Turkenburg M., Dodson E. A graphical user interface to the CCP4 program suite. Acta Crystallogr. D 2003, 59:1131-1137.
33. Rodziewicz-Motowidło S., Iwaszkiewicz J., Sosnowska R., Czaplewska P., Sobolewski E., Szymańska A., Stachowiak K., Liwo A. The role of the Val57 amino-acid residue in the hinge loop of the human cystatin C. Conformational studies of the beta2-L1-beta3 segments of wild-type human cystatin C and its mutants. Biopolymers 2009, 91:373-383.
34. Rose G.D., Gierasch L.M., Smith J.A. Turns in peptides and proteins. Adv. Prot. Chem. 1985, 37:1-109.
35. Szymanska A., Radulska A., Czaplewska P., Grubb A., Grzonka Z., Rodziewicz-Motowidło S. Governing the monomer-dimer ratio of human cystatin C by single amino acid substitution in the hinge region. Acta Biochim. Pol. 2009, 56:455-463.
36. Teng T.-Y. Mounting of crystals for macromolecular crystallography in a free-standing thin film. J. Appl. Crystallogr. 1990, 23:387-391.
37. Turk V., Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 1991, 285:213-219.
38. Vagin A., Teplyakov A. MOLREP: an automated program for molecular replacement. J. Appl. Cryst. 1997, 30:1022-1025.
39. Wahlbom M., Wang X., Lindström V., Carlemalm E., Jaskólski M., Grubb A. Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping. J. Biol. Chem. 2007, 282:18318-18326.
40. Wilmot C.M., Thornton J.M. Analysis and prediction of the different types of β-turn in proteins. J. Mol. Biol. 1988, 203:221-232.
41. Zhang Y., Skolnick J. TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res. 2005, 33:2302-2309.